2002.-To determine whether reactive oxygen species (ROS) play an essential role in hypoxic pulmonary vasoconstriction (HPV) and the cellular locus of ROS production and action during HPV, we measured internal diameter (ID) at constant transmural pressure, lucigenin-derived chemiluminescence (LDCL), and electron paramagnetic resonance (EPR) spin adduct spectra in small distal porcine pulmonary arteries, and dichlorofluorescein (DCF) fluorescence in myocytes isolated from these arteries. Hypoxia (4% O 2) decreased ID, increased DCF fluorescence, tended to increase LDCL, and in some preparations produced EPR spectra consistent with hydroxyl and alkyl radicals. Superoxide dismutase (SOD, 150 U/ml) or SOD ϩ catalase (CAT, 200 U/ml) did not alter ID during normoxia but reduced or abolished the constriction induced by hypoxia. SOD also blocked HPV in endotheliumdenuded arteries after restoration of the response by exposure to 10 Ϫ10 M endothelin-1. Confocal fluorescence microscopy demonstrated that labeled SOD and CAT entered pulmonary arterial myocytes. SOD, SOD ϩ CAT, and CAT blocked the increase in DCF fluorescence induced by hypoxia, but SOD ϩ CAT and CAT also caused a stable increase in fluorescence during normoxia, suggesting that CAT diminished efflux of DCF from cells or oxidized the dye directly. We conclude that HPV required increased concentrations of ROS produced by and acting on pulmonary arterial smooth muscle rather than endothelium. vascular smooth muscle; endothelium; electron paramagnetic resonance; dichlorofluorescein; lucigenin; superoxide dismutase; catalase REACTIVE OXYGEN SPECIES (ROS) are thought to play important roles in a wide variety of cellular processes (10, 22) . In the pulmonary circulation, O 2 -dependent changes in ROS concentrations in pulmonary arterial smooth muscle have been proposed by several laboratories to mediate hypoxic pulmonary vasoconstriction (HPV); however, the details of these hypotheses differ greatly. On one hand, hypoxia is thought to reduce production of ROS by the mitochondrial electron transport chain (METC) (3) or a microsomal NADH oxidase (33, 34). On the other hand, hypoxia is thought to increase production of ROS by the METC (53) or a sarcolemmal NADPH oxidase (13, 30, 59) . Proposals for effector pathways are equally varied and include redox-dependent inactivation of sarcolemmal voltagedependent potassium channels and secondary membrane depolarization (57), NADH-dependent enhancement of cyclic ADP ribose production and secondary activation of ryanodine receptors and calcium release from sarcoplasmic reticulum (60), and H 2 O 2 -and catalase-dependent, nitric oxide-independent activation of soluble guanylate cyclase (33, 34) .
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None of these proposals includes endothelial cells, which can be a potent source of ROS and other vasoactive factors (7, 29) , and are thought to play an essential role in HPV (52) . In small distal porcine pulmonary arteries, we found that HPV was 1) similar to HPV in isolated or intact lungs in terms of magnitude, O 2 dependence, temporal characteristics, and inhibition by Ca 2ϩ -free conditions or nifedipine; 2) abolished by endothelial denudation or the endothelin-1 (ET-1) receptor antagonist BQ123; and 3) restored in endothelium-denuded arteries primed by exposure to a threshold concentration of ET-1 (28) . Furthermore, in myocytes isolated from these vessels, ET-1 priming potentiated a small but significant hypoxic contraction nearly eightfold (44) . On the basis of these results and observations that ET-1 receptor antagonists inhibited HPV in intact animals (38) , we concluded that full expression of HPV required basal release of ET-1 from endothelium to facilitate mechanisms of hypoxic reactivity in pulmonary arterial smooth muscle; however, the role of ROS remained unclear. In this context, we found it interesting that ROS altered production of ET-1 in endothelial cells (31) , whereas ET-1 altered production of ROS in vascular smooth muscle (55, 56) .
The present study was performed to determine whether ROS are required for HPV, how ROS in pulmonary arteries are altered by hypoxia, and whether the cellular site of ROS production and action during HPV is pulmonary arterial smooth muscle or endothelium.
METHODS

Isolated Pulmonary Arteries
Male pigs (20-25 kg) were anesthetized with ketamine (30 mg/kg im) followed by pentobarbital sodium (12.5 mg/kg iv). After exsanguinating the animal of the femoral arteries, we rapidly removed the lungs and placed them in ice-cold KrebsRinger bicarbonate (KRB) solution containing (in mM): 118.3 NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 2.5 CaCl2, 25 .0 NaHCO3, and 11.1 glucose. Under a dissecting microscope, 1-mm segments of pulmonary arteries [outer diameter (OD) 100-150 m] were isolated from seventh-generation branches in the top left lobe and carefully cleaned of adventitial tissue.
Measurement of vascular diameter. To measure vasomotor responses, the arterial segments were cannulated at one end with a glass micropipette mounted in a chamber filled with KRB solution equilibrated with 16% O2, 5% CO2, and 79% N2 at 37°C. After securing the vessel to the pipette with a 12-0 nylon monofilament suture, we infused KRB solution slowly until the artery was filled. In some vessels, endothelial cells were disrupted by gently rubbing the intraluminal surface with a steel wire (OD 70 m) followed by perfusion with 2 ml of air and 2 ml of KRB solution (perfusion pressure Ͻ5 mmHg). The other end of the vessel was cannulated with a second micropipette filled with KRB solution. Both cannulas were connected to a reservoir, which was adjusted to set transmural pressure (P tm) at the desired value. Ptm was measured with a pressure transducer positioned at the level of the vessel lumen. The chamber was covered and the vessels superfused at 20 ml/min with recirculating KRB solution (total vol 50 ml) gassed with 16% O 2, 5% CO2, and 79% N2 and maintained at 37°C. The same gas mixture flowed over the surface of the superfusate in the covered chamber. To measure vascular internal diameter (ID), the chamber was placed on the stage of an inverted microscope (Nikon TMS-F, Japan) connected to a video camera (Panasonic, CCTV camera, Japan). The vascular image was projected onto a video monitor, and ID was determined with a video dimension analyzer (Living Systems Instrumentation, Burlington, VT). ID and P tm were recorded continuously (Gould, Cleveland, OH).
Vascular viability testing. Before experiments, arteries were allowed to equilibrate for 20 min at P tm ϭ 10 mmHg. Ptm was then increased to 20 mmHg and thereafter held constant. To test viability, the vessels were exposed to KCl (60 mM) and then to the thromboxane A 2 agonist U-46619 (10 Ϫ9 M), followed by acetylcholine (ACh, 10 Ϫ6 M). After stabilization of responses (5-10 min), agonists were washed out by 15-20 min of nonrecirculating superfusion with fresh KRB solution. Arteries in which ID decreased Ͻ30% after KCl and U-46619 were excluded. Endothelium-intact (Eϩ) vessels were excluded if ACh reversed the U-46619 contraction by Ͻ50%. Endothelium-denuded (EϪ) vessels were excluded if ACh caused any vasodilatation. In some preparations, viability tests were repeated at the end of the experiment.
Exposure to hypoxia. Vasomotor responses to hypoxia were measured in untreated control Eϩ pulmonary arteries (n ϭ 15), Eϩ arteries treated for 30 min with superoxide dismutase (SOD, 150 U/ml, n ϭ 10) or SOD ϩ catalase (CAT, 200 U/ml, n ϭ 6), untreated control EϪ arteries (n ϭ 15), and EϪ arteries treated for 30 min with ET-1 (10 Ϫ10 M, n ϭ 13) or ET-1 ϩ SOD (n ϭ 6), where n is the number of animals as well as vessels. Hypoxia was produced by decreasing O 2 concentration from 16 to 4% in the gas mixture bubbling the reservoir and flowing over the perfusate surface in the chamber. This caused oxygen tension measured with a microelectrode (Microelectrodes, Londonderry, NH) at the vessel to decrease rapidly from 114 Ϯ 1 to 29 Ϯ 1 mmHg (28). Duration of hypoxia was 30 min except in 8 of 15 untreated control EϪ arteries, where it was 60 min. After hypoxia, oxygen concentration was returned to 16%. Responses were quantified as changes in ID (⌬ID) from values at the onset of hypoxia. Data from control arteries and EϪ arteries primed with ET-1 have been previously reported (28) .
Measurement of ROS in pulmonary arteries. To assess production of ROS in Eϩ pulmonary arteries, we used lucigenin-derived chemiluminescence (LDCL) and electron paramagnetic resonance (EPR) spectroscopy. LDCL was measured in arterial segments isolated from five pigs as described above. Two segments, 1 mm in length, were placed into each of four stoppered test tubes containing 1 ml of KRB solution bubbled gently with 16% O 2, 5% CO2, and 79% N2 at 37°C. One pair of tubes served as an experimental group and the other as a control group. After 30 min, baseline production of ROS in the experimental group was assessed by adding lucigenin (bis-N-methyacidinium nitrate, 20 M) to one of the tubes immediately before transfer to a luminometer (Lumat LB 9506; E. G. and G. Berthold, Bad Wildbad, Germany) for continuous recording of emitted light as relative light units per second. In the other test tube of the experimental pair, the gas mixture was then switched to 4% O 2, 5% CO2, and 91% N2. After 30 min of exposure, LDCL in this tube was measured in the same manner. Baseline and exposure measurements were repeated in the control pair of test tubes, which were treated similarly but not exposed to hypoxia.
We performed EPR spectroscopy in Eϩ pulmonary artery segments isolated from seven pigs. Three arterial segments, 1 mm in length, were placed into each stoppered test tube, which contained 1 ml of KRB solution bubbled with 16% O2, 5% CO2, and 79% N2 at 37°C. After a 1-h equilibration period, the gas mixture was either switched to 4% O2, 5% CO2, and 91% N2 or not changed, and the spin trap, 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline-N-oxide (DEPMPO, 40 mM) (12) , was added to the tube. After a 1-h exposure period, 50-l samples of the media bathing the vessels were taken into microcapillary tubes, which were placed in a 3-mm EPR quartz tube centered in the TM 110 cavity of a Bruker ER 300 EPR spectrometer operating at X-band. Serial acquisitions of spectra were performed at 25°C by accumulating 10 1-min scans per spectrum for up to 30 min. The following data acquisition parameters were used: microwave frequency, 9.7829 GHz; sweep width, 160 G; microwave power, 20 mol wt; modulation amplitude, 0.5 G; modulation frequency, 100 kHz; time constant 328 ms. The digital data were processed using custom-developed software (SPEX and EPRDAP) capable of component simulation, fitting, and quantification (21) .
Pulmonary arterial smooth muscle cells and endothelial cells. We used primary cultures of smooth muscle cells from porcine distal pulmonary arteries to assess direct effects of hypoxia on production of ROS by smooth muscle. As in our previous study (44) , we used the method of Clapp and Gurney (6) to isolate the cells. After removal of adventitial tissue from pulmonary artery segments obtained as described above, we opened the vessels longitudinally and removed endothelium by rubbing the intimal surface with a cotton swab. The cleaned vessels were cut into small pieces and transferred to a vial filled with 10 ml of dissociation solution containing (in mM): 0.16 CaCl2, 110 NaCl, 5 KCl, 2 MgCl2, 10 HEPES, 10 NaHCO3, 0.5 KH2PO4, 0.5 NaH2PO4, 10 glucose, 0.04 phenol red, 0.49 EGTA, and 10 taurine as well as papain (3.2 U/ml), bovine serum albumin (0.2 mg/ml), penicillin (100 U/ml), and streptomycin (0.1 mg/ml). pH was titrated to 7.4 with NaOH. We stored the vessel fragments in this solution overnight at 4°C to allow papain to penetrate the tissue. The next day, the tissue was transferred to fresh dissociation solution containing dithiothreitol (0.1 mM) and equilibrated with 16% O 2, 5% CO2, and 79% N2 at 37°C (pH 6.6) to activate the enzyme. After 20 min of digestion, the tissue was transferred to fresh dissociation solution equilibrated with 16% O 2, 5% CO2, and 79% N2 at room temperature. Cells were dissociated by trituration with a wide-bore pipette and plated on autoclaved glass coverslips in petri dishes. After 30-40 min to allow cell adherence, we added growth media to the dishes and placed them in an incubator (37°C, 5% CO 2 in air). Growth medium was Clonetics SmGM-2 (BioWhittaker, Walkersville, MD), composed of basal media (Clonetics SmBM) supplemented with fetal bovine serum (5%), bovine insulin (5 g/ml), human fibroblast growth factor (2 ng/ml), human epidermal growth factor (0.5 ng/ml), gentamycin (50 g/ml), amphotericin (50 ng/ml), streptomycin (50 g/ml), and penicillin (50 U/ml). When cells had grown to ϳ50% confluence (13.5 Ϯ 1.9 days), medium was changed to Clonetics SmBM containing 0.3% fetal bovine serum, and the cells were maintained in this serum-starved state until study (6.4 Ϯ 0.4 days). Throughout the period of culture, medium was renewed at 2-to 3-day intervals. Cells were identified as pulmonary arterial smooth muscle cells (PASMCs) by their elongated spindle shape and positive immunoperoxidase staining for ␣-actin (15, 16) . Staining was performed with commercially available kits (Avidin/Biotin Blocking kit, Vectastain Elite ABC reagent, and Vector SG Substrate kit; Vector Laboratories, Burlingame, CA) using mouse anti-␣-actin and biotinylated goat anti-mouse IgG2a (Roche Molecular Biochemicals, Indianapolis, IN) as primary and secondary antibodies, respectively.
In a few protocols (see below), we used rat PASMCs or bovine pulmonary arterial endothelial cells (PAECs). Rat PASMCs were isolated enzymatically from greater than fourth-generation pulmonary arteries obtained from 250-to 350-g male Wistar rats as previously described (46) . Culture conditions were the same as for porcine PASMCs except that primary cultures were exposed to growth media for 4-6 days and serum starved for 1-2 days before study due to a faster rate of growth. Bovine PAECs frozen at passage 3 were obtained from Cell Systems (Kirkland, WA) and cultured in DMEM (Life Technologies, Rockville, MD) supplemented with 20% fetal bovine serum (Sigma, St. Louis, MO), 15 g/ml of endothelial cell growth supplement (Upstate Biotechnology, Lake Placid, NY), 1% antibiotic-antimycotic solution (Life Technologies), and 0.1 mM nonessential amino acids (Life Technologies). When PAECs were 30-40% confluent at passage 5-6, they were exposed to medium without serum, nonessential amino acids, and endothelial cell growth supplement for 1-2 days before study.
Measurement of dichlorofluorescein fluorescence. For cell perfusion and measurement of intracellular ROS, coverslips with porcine PASMCs were mounted in a closed polycarbonate chamber (RC-21BR; Warner Instrument, Hamden, CT) clamped in a heated aluminum platform (PH-2, Warner Instrument) on the stage of a laser-scanning confocal fluorescence microscope (LSM-510; Carl Zeiss, Thornwood, NY). The chamber was perfused at 0.5 ml/min with KRB solution containing 5 M dihydro-2Ј,7Ј-dichlorofluorescein diacetate (DCFH2-DA). The perfusate was equilibrated with 16 or 4% O2-5% CO2-balance N2 at 38°C in heated reservoirs and led via stainless steel tubing and a manifold to an inline heat exchanger (SF-28, Warner Instrument), which rewarmed the perfusate just before it entered the cell chamber. The temperature of the heat exchanger and chamber platform was controlled by a dual-channel heater controller (TC-344B, Warner Instrument). Perfusion of a cell chamber modified to allow continuous measurement of oxygen tension (Microelectrodes) and temperature at the coverslip confirmed maintenance of temperature at 37°C and oxygen tensions at 112 Ϯ 2.0 and 34 Ϯ 1.8 mmHg when reservoir O 2 concentrations were 16 and 4%, respectively. After the reservoir O 2 concentration was changed, PO 2 in the chamber changed with a half-time of 2.6 Ϯ 0.3 min.
Initially, porcine PASMCs were perfused under normoxic conditions for 1-3 h to allow DCFH 2-DA uptake and stabilization of cell fluorescence. Upon cell entry, DCFH 2-DA is cleaved by cellular esterases to DCFH 2. DCFH2 remains inside the cell, where it can be oxidized by ROS to form the fluorescent product dichlorofluorescein (DCF). Thus an increase in DCF fluorescence suggests increased intracellular concentrations of ROS. In these experiments, two-dimensional images (230 ϫ 230 m; acquisition time 231 ms) of intracellular DCF fluorescence (Ͼ505 nm) were acquired at 2-min intervals using a ϫ40 objective (Zeiss Plan-Neofluor, numerical aperture 1.3) and a helium-neon laser to deliver a scanning excitation line at 488 nm. After obtaining baseline images under normoxic conditions, we exposed cells to 4% O 2 for 30 min followed by 16% O2 for 20 min. This protocol was performed in untreated cells (n ϭ 10 experiments) and cells treated with SOD (150 U/ml, n ϭ 8), CAT (200 U/ml, n ϭ 6), or SOD ϩ CAT (n ϭ 4). Perfusion with antioxidant enzymes began 30-40 min before the onset of hypoxia and continued throughout the experiment. To analyze images, we defined multiple regions of interest representing 5-19 cells and a single cell-free area. Fluorescence intensity measured in the cell-free region was taken as background and subtracted from fluorescence in other regions. These differences were calculated for each cell at each time, normalized by values at the onset of hypoxia, and averaged across cells. Averages for each experiment were then used to determine group means and perform statistical comparisons among groups.
To further evaluate the effects of CAT during normoxia, we also measured DCF fluorescence in normoxic rat PASMCs and bovine PAECs. After a 1-to 2-h stabilization period, fluorescent images were obtained at 2-min intervals as described above before and during a 40-min exposure to CAT (200 U/ml, n ϭ 3 for each cell type) or heat-inactivated CAT (n ϭ 3 for each cell type).
Imaging of fluorescein-conjugated SOD and CAT. To determine whether perfusate SOD and CAT entered porcine PASMCs, we perfused cells for 1 h with normoxic KRB solution containing either SOD or CAT labeled with FITC after a 1-to 2-h stabilization period during which the perfusate was normoxic KRB solution without fluorescent indicators. SOD and CAT were labeled by mixing with a 50-fold higher molar concentration of FITC for 1 h at room temperature in phosphate-buffered saline alkalinized with NaHCO3 (final concentration ϳ0.1 M). To remove unbound FITC, the reaction mixture was passed through columns containing polyacrylamide gel (Bio-Spin P-6 and P-30; Bio-Rad Laboratories, Hercules, CA) with molecular weight exclusion limits of 6,000 (SOD) or 40,000 (CAT). If we assume complete recovery, the final concentration of FITC-labeled proteins in perfusate was 1,000 (CAT) or 200 (SOD) U/ml. The higher concentration of FITC-labeled CAT was necessary to permit detection by laser-scanning confocal microscopy. We obtained sequential confocal images in the x-y plane (230 ϫ 230, 115 ϫ 115, or 77 ϫ 77 m) at 0.3-m intervals in the z plane (Z-series) of cells fluorescing at Ͼ505 nm in response to excitation at 488 nm. Z-series images of the same cells were acquired at the same settings immediately before and 1 h after exposure to labeled SOD or CAT followed by Ն15 min washout with normal KRB. Control cells were subjected to the same protocol, except that SOD or CAT was not added to the labeling reaction mixture.
Drugs and Reagents
ACh, SOD, and CAT were purchased from Sigma Chemical. For cell studies, CAT was also obtained from Calbiochem (San Diego, CA). ET-1 was purchased from American Peptide (Sunnyvale, CA) and U-46619 from Cayman Chemical (Ann Arbor, MI). Stock solutions of SOD and CAT were prepared in 0.05 M phosphate buffer and stored in aliquots at Ϫ20°C until use. ACh and ET-1 were prepared each day in deionized water and stored at 4°C until use. DCFH 2-DA, lucigenin, and FITC were obtained from Molecular Probes (Eugene, OR). Stock solutions in DMSO (DCFH 2-DA, FITC) or deionized water (lucigenin) were protected from light and stored in aliquots at Ϫ20°C until use. DEPMPO was a gift from Dr. Valerie Roubaud (Marseille, France) and was prepared as reported (12) . Concentrations are expressed as final molar concentrations in perfusate.
Data Analysis
T-tests and analysis of variance were used for statistical comparisons, taking repeated measures into account when appropriate. When analysis of variance yielded a significant F ratio, least significant differences were calculated for pairwise comparison among means. We assumed that P values Յ0.05 indicated statistical significance. Values given in the text are means Ϯ SE.
RESULTS
Viability Tests in Pulmonary Arteries
As shown in Table 1 , KCl and U-46619 caused vigorous constriction in both Eϩ and EϪ arteries. ACh reversed constrictions induced by U-46619 in Eϩ arteries but had no effect in EϪ arteries. Viability tests were repeated under normoxic conditions at the end of the experiment in 14 untreated control Eϩ arteries, 5 Eϩ arteries treated with SOD, and 6 Eϩ arteries treated with SOD ϩ CAT (Fig. 1) . Vasoconstrictor responses to KCl at the end of the experiment were decreased compared with responses at the beginning of the experiment in untreated and SOD-treated arteries (⌬ID ϭ Ϫ138 Ϯ 10 vs. Ϫ30 Ϯ 11 m and Ϫ145 Ϯ 14 vs. 
Ϫ40 Ϯ
18 m, respectively) but not altered in arteries treated with SOD ϩ CAT (⌬ID ϭ Ϫ175 Ϯ 13 vs. Ϫ146 Ϯ 19 m). Vasoconstrictor responses to U-46619 were not changed in any group. Vasodilator responses to ACh were decreased at the end of the experiment in untreated and SOD-treated arteries (⌬ID ϭ 114 Ϯ 15 vs. 26 Ϯ 15 m and 102 Ϯ 29 vs. 21 Ϯ 20 m, respectively) but not altered in arteries treated with SOD ϩ CAT (⌬ID ϭ 116 Ϯ 14 vs. 99 Ϯ 13 m).Eϩ 210 Ϯ 11 69 Ϯ 6* Ϫ67 Ϯ 2 199 Ϯ 11 103 Ϯ 9* 220 Ϯ 9 ‡ Ϫ48 Ϯ 4 169 Ϯ 27 EϪ 206 Ϯ 9 7 4 Ϯ 5* Ϫ64 Ϯ 2 185 Ϯ 8 7 9 Ϯ 6* † 78 Ϯ 6 † Ϫ56 Ϯ 3 Ϫ4 Ϯ 3
Hypoxic Constriction in Pulmonary Arteries
In untreated Eϩ arteries, ID decreased from 198 Ϯ 10 to 185 Ϯ 9 m in the 30-to 40-min normoxic period preceding the onset of hypoxia. This spontaneous change in normoxic baseline ID was not different from that observed over the same period of time after treatment with SOD or SOD ϩ CAT (195 Ϯ 21 to 201 Ϯ 19 m and 196 Ϯ 23 to 179 Ϯ 23 m, respectively). As shown in Fig. 2 , decreasing O 2 concentration from 16 to 4% for 30 min in untreated control Eϩ arteries caused vigorous reversible constriction (⌬ID at 30 min ϭ Ϫ57 Ϯ 10 m), which was blocked by SOD or SOD ϩ CAT (⌬ID ϭ Ϫ17 Ϯ 7 and Ϫ5 Ϯ 9 m, respectively). The effects of SOD ϩ CAT on HPV were not significantly different from those of SOD alone. Although endothelial denudation (Fig. 3) abolished hypoxic constriction (⌬ID ϭ Ϫ8 Ϯ 6 m), the response could be restored by pretreating ("priming") EϪ arteries with 10 Ϫ10 M ET-1 (⌬ID ϭ Ϫ39 Ϯ 8 m). This restored hypoxic constriction was also blocked by SOD (⌬ID ϭ 4 Ϯ 3 m).
ROS in Pulmonary Arteries
LDCL in porcine distal pulmonary artery segments (Fig. 4) was maximum immediately on placing samples in the luminometer and declined progressively thereafter (Fig. 4A) , perhaps due to cooling. Analysis of variance did not reveal significant differences in the time course of LDCL between baseline and exposure periods in either control or experimental groups. Similarly, maximum LDCL measured in the control group was not altered (Fig. 4B) ; however, maximum LDCL measured in the experimental group increased during hypoxia. This increase approached but did not achieve statistical significance (P Ͻ 0.07).
In a further attempt to determine whether porcine distal pulmonary arteries produced radicals during hypoxia and to characterize the species generated, we performed EPR spectroscopy using DEPMPO as a spintrapping molecule. Representative EPR spectra are shown in Fig. 5 . No spin adduct signals were detected in four of four experiments in vessels subjected to normoxia (Fig. 5A) ; however, radicals were detected in Fig. 2 . Effects of SOD (150 U/ml) and SOD ϩ CAT (200 U/ml) on vasomotor responses of porcine distal pulmonary arteries (PA) with intact endothelium (Eϩ) to hypoxia. of lucigenin-derived chemiluminescence in porcine distal pulmonary arteries. Control vessels were subjected to normoxia during both baseline and exposure periods. Experimental vessels were subjected to normoxia during the baseline period and hypoxia during the exposure period. RLU, relative light units.
three of six experiments in vessels subjected to hypoxia (Fig. 5B) . These hypoxic spectra were composed of multiple signals, which were identified as hydroxyland carbon-centered alkyl radical adducts of DEPMPO (42) by simulating the signals independently (Fig. 5, C and D) and adding them together (Fig. 5E ) to match the experimentally measured spectrum (Fig. 5B) . The good correlation between experimental and compositesimulated spectra suggests that hydroxyl-and carboncentered alkyl radicals were produced by pulmonary arteries during hypoxia.
ROS in PASMCs
During hypoxia, DCF fluorescence increased in untreated PASMCs from distal porcine pulmonary arteries (Figs. 6 and 7A) , reaching a plateau after 10-15 min of hypoxia and returning nearly to baseline levels on resumption of normoxia. This response was blocked in PASMCs treated with SOD, SOD ϩ CAT, or CAT. As shown in Fig. 7B , CAT or SOD ϩ CAT (but not SOD) caused an increase in baseline DCF fluorescence during the normoxic period preceding hypoxia, which achieved a stable plateau after 30-40 min. CAT also increased DCF fluorescence in rat PASMCs and bovine PAECs; however, the increase was smaller in PAECs than in PASMCs (Figs. 7B and 8) . In contrast, DCF fluorescence fell slightly in rat PASMCs and bovine PAECs treated with heat-inactivated CAT (Fig. 8) . In Figs. 7B and 8, fluorescence intensity (F) is expressed as differences from background in arbitrary fluorescence units. Initial values of F were lower in PASMCs treated with CAT or SOD ϩ CAT because detector gain was reduced to avoid saturation of the photometer.
Confocal images of PASMC fluorescence after exposure to FITC-labeled SOD or CAT in perfusate are shown in Fig. 9 . Before exposure, myocytes exhibited low-intensity autofluorescence localized to spherical regions in cytoplasm, which were 1-2 m in diameter and consistent with mitochondria. After exposure to labeled SOD or CAT, this fluorescence diminished, and new high-intensity fluorescence appeared on cell surfaces and small punctate and linear-reticular regions within the cells. In control cells, where FITC alone was added to the labeling reaction mixture, baseline autofluorescence was slightly diminished and no new fluorescence appeared.
DISCUSSION
Our previous studies in porcine distal pulmonary arteries and myocytes isolated from these vessels demonstrated that HPV was generated by mechanisms intrinsic to smooth muscle, but full expression of HPV required basal release of ET-1 from endothelium (28, 44) . In this study, we provide evidence that HPV required increased generation of superoxide anions (O 2 Ϫ ⅐) and that O 2 Ϫ ⅐ or ROS derived from O 2 Ϫ ⅐ were produced by and acted on pulmonary arterial smooth muscle. First, superfusion of distal porcine pulmonary arteries with SOD, which metabolizes O 2 Ϫ ⅐ to H 2 O 2 , did not alter vasomotor tone during normoxia but inhibited constriction induced by hypoxia (Fig. 2) , suggesting that HPV depended on increased production of O 2 Ϫ ⅐ during hypoxia. Second, these effects of SOD were not altered by CAT (Fig. 2) , which metabolizes H 2 O 2 to H 2 O, suggesting that SOD acted by catabolizing O 2 Ϫ ⅐ rather than synthesizing H 2 O 2 . Third, SOD blocked HPV in endothelium-denuded, endothelin-primed pulmonary arteries (Fig. 3) , suggesting that the source and site of action of O 2 Ϫ ⅐ involved in HPV was pulmonary arterial smooth muscle rather than endothelium. Fourth, measurements of LDCL and EPR spectroscopy in distal pulmonary arteries (Figs. 4 and 5 ) and DCF fluorescence in PASMCs isolated from these vessels (Figs. 6 and 7) suggested that hypoxia increased intracellular synthesis and/or release of ROS. Fifth, SOD and CAT entered PASMCs (Fig. 9 ) and blocked the increase in DCF fluorescence caused by hypoxia (Fig. 7) . Several previous studies have examined the effects of antioxidants and inhibitors of antioxidant enzymes on HPV. Diethyldithiocarbamic acid (DETCA) and triethylenetetramine (TETA), inhibitors of SOD, potentiated hypoxic contractions in guinea pig pulmonary arteries (1), and CAT inhibited hypoxic contractions in sheep pulmonary veins (45); however, SOD did not alter hypoxic contractions in sheep pulmonary arteries (9) . In isolated lungs, SOD potentiated or did not affect HPV (5, 58), whereas DETCA, TETA, and the antioxidants nitro blue tetrazolium, pyrrolidine dithiocarbamate, and ebselen inhibited HPV (53, 58, 59 ). Aminotriazole, an inhibitor of CAT, did not alter a small hypoxic pressor response in isolated rat lungs (36) but nonspecifically inhibited HPV in isolated rabbit lungs (58) . The inconsistency among these results could be due to variability in type, concentration, source, and location of ROS produced; specificity and efficacy of the interventions employed; state of cellular antioxidant defenses; alteration of ROS-mediated physiological responses by ROS-mediated injury; and other factors. Although this inconsistency makes it difficult to distinguish which ROS might be involved in HPV, most studies suggest that ROS plays a role. Indeed, HPV may depend on changes in redox state inducible by a variety of pathways instead of a particular ROS. In our experiments, however, O 2 Ϫ ⅐ appeared to be essential. KCl-induced constrictions and ACh-induced dilations were diminished after exposure to hypoxia and reoxygenation in control pulmonary arteries and arteries treated with SOD but not arteries treated with SOD ϩ CAT (Fig. 1) . In a previous report (28), we showed that vasomotor responses to KCl and ACh were more depressed at the end of the experiment in arteries exposed to hypoxia than in time-control vessels exposed only to normoxia. Together, these results suggest that ROS-induced injury occurred in our vessels; however, it is unlikely that SOD inhibited HPV by enhancing injury through increased production of H 2 O 2 or its products because addition of CAT to SOD did not alter the inhibitory effects of SOD on HPV (Fig. 2) . The cellular source of ROS responsible for injury was probably not endothelium because endothelial denudation did not prevent reduction of KCl responses after reoxygenation (data not shown). Furthermore, ROS production in porcine PAECs, unlike bovine cells, was not enhanced by anoxia reoxygenation (51, 61, 62) .
Anoxia alone decreased ROS production in cultured PAECs (61, 62) ; however, this might not be true for less severe degrees of hypoxia in freshly isolated vessels. To determine whether endothelium-derived ROS contributed to HPV, we measured the effects of SOD on HPV in endothelium-denuded pulmonary arteries primed with the endothelium-derived contracting factor, ET-1. This approach was based on our previous observations that exposure to threshold concentrations (10 Ϫ10 M) of ET-1 markedly enhanced hypoxic contractions in porcine PASMCs and prevented abolition of HPV by endothelial denudation in porcine pulmonary arteries (28, 44) . As shown in Fig. 3 , SOD blocked hypoxic constriction in these vessels. These results indicate that HPV depended on ROS produced by and acting on pulmonary arterial smooth muscle instead of endothelium. Consistent with previous results (20, 53) , hypoxia increased DCF fluorescence in PASMCs (Figs. 6 and 7) . In theory, increased DCF fluorescence could result from enhanced entry of DCFH 2 -DA into cells; enhanced intracellular deacetylation of DCFH 2 -DA to DCFH 2 ; enhanced intracellular oxidation of DCFH 2 to DCF; diminished metabolism of DCF to a nonfluorescent product; or diminished leakage of DCF out of cells. With respect to the first two possibilities, we exposed PASMCs to DCFH 2 -DA throughout the experiment, including the 1-to 3-h period before hypoxia, to maximize intracellular DCFH 2 concentration. The last two possibilities are suggested by the return of DCF fluorescence to baseline levels upon reoxygenation (Fig. 7) . To our knowledge, DCF metabolism has not been studied in PASMCs. In cancer cells, leakage of calcein, a dye closely related to DCF, was due in part to ATPdependent extrusion by plasma membrane transporters such as P-glycoprotein and multidrug resistance protein (11, 14) . Whether these proteins play a role in PASMCs is unknown. Although the possibility that hypoxia inhibited DCF metabolism or leakage cannot be ruled out, our observation that SOD and/or CAT blocked the increase in fluorescence induced by hypoxia (Fig. 7A) suggests that hypoxia acted by enhancing intracellular oxidation of DCFH 2 .
In reaction solutions, H 2 O 2 but not O 2 Ϫ ⅐ oxidized DCFH 2 to DCF; however, in cells, DCFH 2 oxidation could occur via a variety of pathways (24, 41) . Thus an increase in DCF fluorescence may be more accurately interpreted to indicate an increase in oxidative stress rather than increased production of a particular ROS. Our observation that both SOD and CAT inhibited the increase in DCF fluorescence caused by hypoxia (Fig.  7A) The inhibitory effect of CAT on DCF fluorescence during hypoxia (Fig. 7A ) confirms previous observations in rat PASMCs (20) and is consistent with the recent demonstration that overexpression of CAT attenuated hypoxia-induced increases in intracellular calcium concentration in PASMCs (54) . However, our results should be interpreted with caution because CAT and SOD plus CAT also caused an unexpected increase in normoxic baseline fluorescence (Fig. 7B) , indicating that CAT increased DCF concentration. This increase did not result from reaction of CAT with DCFH 2 -DA in perfusate, because fluorescence in "background" regions of interest was not altered (data not shown) and was in any case subtracted from fluorescence in cells. It is also unlikely that the increase was caused by a constituent of the enzyme preparation other than CAT, because different lots of CAT preparations from two companies increased fluorescence while heat-inactivated CAT did not (Fig. 8) . Qualita- tively, the effect of CAT on DCF fluorescence was similar in PASMCs from pig and rat and PAECs from cow, suggesting that it did not depend on species or cell type; however, increases in fluorescence were larger in PASMCs than in PAECs (Fig. 8) , consistent with previous observations that CAT entered vascular smooth muscle more readily than endothelium (50) . Increased intracellular DCF concentrations could result from decreased elimination of DCF from cells or increased oxidation of DCFH 2 . With respect to the former, CAT may have decreased cell injury induced by H 2 O 2 or its products and thereby limited leakage of DCF across cell membranes. With respect to the latter, it seems unlikely that CAT and SOD plus CAT increased production of ROS, which then caused secondary oxidation of DCFH 2 ; however, CAT may have oxidized DCFH 2 directly, as has been reported for other heme proteins (37) . CAT compound I, the oxyferryl -cation porphyrin radical produced by reaction of ferric CAT with H 2 O 2 , can regenerate ferric CAT by oxidizing a variety of hydrogen donors, including ethanol, methanol, phenol, and ascorbate (19, 23, 39, 49) . Although steric hindrance would be expected to exclude hydrogen donors as large as DCFH 2 from the heme-containing active site of the native enzyme (23), partial denaturation of lyophilized CAT might increase accessibility and permit oxidation of larger molecules (48) . Alternatively, charge transfer from the active site of CAT compound I to its surrounding protein might allow reactions with larger molecules, as proposed for oxidation of NADPH by compound I (18, 40) . Further investigation will be necessary to determine which of these explanations is correct.
Because of their size, SOD (mol wt ϳ31,200) and CAT (mol wt ϳ250,000) are frequently assumed not to enter cells. If this assumption were true, the inhibitory effects of SOD and CAT on HPV (Fig. 2) and DCF fluorescence during hypoxia (Fig. 7) would have to be due to catabolism of ROS released from myocytes into the extracellular space. To test this assumption, we used laser-scanning confocal fluorescence microscopy and FITC protein labeling to determine whether SOD and CAT entered PASMCs in our experiments. As shown in Fig. 9 , FITC-labeled SOD and CAT were detected in PASMCs, whereas free FITC subjected to the same labeling and separation protocol was not. These results are consistent with previous reports that SOD entered lung cells after intratracheal administration (8, 43) and that CAT entered vascular smooth muscle cells after administration into culture media (50) . Thus the effects of SOD and CAT (Figs. 2 and 7) could be due to catabolism of ROS in the intracellular space (i.e., it is not necessary to conclude that ROS released from myocytes mediated HPV by acting at the external sarcolemmal surface or at intracellular loci after reentering cells).
The effects of hypoxia on DCF fluorescence (Figs. 6 and 7) confirm previous assessments of ROS production in PASMCs (20, 30, 53) ; however, studies in isolated lungs (4, 32) , pulmonary arteries (32, 33) , and pulmonary arterial homogenates (35) suggested that ROS concentrations decreased during hypoxia. These discrepancies could be due to production of ROS by cells other than PASMCs, limitation of ROS production by severe levels of hypoxia, destruction of a necessary cellular milieu, or use of proximal pulmonary arteries instead of small distal pulmonary arteries, which are thought to be the major locus of HPV (47) . In our experiments, hypoxia increased LDCL in small distal porcine pulmonary arteries (Fig. 4) , consistent with increased O 2 Ϫ ⅐ production; however, this increase did not achieve statistical significance (P Ͻ 0.07). Moreover, the lucigenin concentration needed to detect luminescence (20 M) may not have been low enough to avoid artifacts due to lucigenin redox cycling (25) (26) (27) . We, therefore, repeated these experiments using EPR spectroscopy and the spin trap DEPMPO to assess ROS production. Hydroxyl and alkyl spin adducts, which could be produced secondary to O 2 Ϫ ⅐ generation, were detected in three of six preparations exposed to hypoxia and zero of four preparations exposed to normoxia (Fig. 5) . Thus neither LDCL nor EPR spectroscopy provided decisive evidence that hypoxia increased ROS generation in distal pulmonary arteries. Possibly, this was due to an inadequate amount of tissue. Alternatively, the absence of distending pressure may have played a role, since stretch has been found to enhance ROS production in both endothelium and vascular smooth muscle (2, 17) . In any case, LDCL and EPR spectroscopy in distal pulmonary arteries provided results consistent with the significant increases in DCF fluorescence caused by hypoxia in myocytes from these vessels (Figs. 6 and 7) .
Our results add to a growing consensus that HPV depends on ROS produced by and acting on pulmonary arterial smooth muscle; however, more work will be necessary to clarify the intracellular sources of ROS required for HPV, the affects of hypoxia on these sources, and the transduction pathways involved.
